Osteolytic Bone Metastases of Breast Cancer

Name	Development Level	Target Family

Name	Description
pamidronic acid	inhibits osteolytic bone lesions; inhibits the mevalonate pathway, which is required for the prenylation of the small GTPase; RN given refers to parent cpd

TCRDv4.6.9
DrugCentral Indication
DrugCentral
pamidronic acid